Xaviar M. Jones
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xaviar M. Jones has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Gamal-Eldin Ibrahim
Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, United States of America
1 shared publication- Ahmed I. Ahmed1 shared publication
- Alessandra Ciullo
Smidt Heart Institute, Cedars-Sinai Heart Institute, Los Angeles, United States of America
1 shared publication - Anh Nguyen
Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, United States of America
1 shared publication - Attila Feher
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.F.).
1 shared publication - Bailey A. Frohlich1 shared publication
Latest Publications
- Open Access
- 10 April 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 29
Association of rheumatoid arthritis with major adverse cardiovascular events despite normal myocardial perfusion imaging
- 10 April 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 29
Open AccessAssociation of rheumatoid arthritis with major adverse cardiovascular events despite normal myocardial perfusion imaging
- Open Access
- 22 January 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (5)
Small noncoding RNA TY2 enhances efferocytosis and improves outcomes in a mouse model of sepsis
TY2 is a drug based on a natural compound with potent anti-inflammatory effects. TY2 improved outcomes in mice with severe bacterial infection.
- 22 January 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (5)
Open AccessSmall noncoding RNA TY2 enhances efferocytosis and improves outcomes in a mouse model of sepsis
TY2 is a drug based on a natural compound with potent anti-inflammatory effects. TY2 improved outcomes in mice with severe bacterial infection.